Full List Of Stories
Pfizer lifts outlook on strong Q2 sales
US pharma giant Pfizer lifted its full-year profit forecast on Tuesday after second-quarter sales of its Covid vaccine and antiviral treatment came in better than expected, along with contributions from new cancer treatments and sales of its heart disease drug.
Europe midday: Shares hold gains ahead despite surprise German GDP fall
European markets were higher on Tuesday amid another earnings dump as investors also looked ahead to rate decisions from the US and UK, while Germany recorded a surprise economic contraction in the second quarter.
Europe open: Shares up ahead of Fed, BoE; St James's Place surges
European markets opened higher Tuesday amid another earnings dump as investors also looked ahead to rate decisions from the US and UK.
Paragon holds guidance as volumes, margins perform
Paragon Bank confirmed full-year guidance as volumes margins and costs during the third quarter were in line with expectations.
Glencore to reveal decision on coal demerger next week
Commodities miner and trader Glencore held annual production guidance and said it would reveal whether a planned demerger of its coal and carbon steel assets would go ahead at interim results next week.
UK's FCA considering redress scheme for motor finance claims
The UK’s financial watchdog said it was considering a compensation scheme for motor finance customers who complained about commission payments but was extending a deadline for companies to respond.
BHP, Lundin bid $3.25bn bid for Filo to expand copper presence
Australian Mining giant BHP rebounded from its failure to buy rival Anglo American and announced it would expand its copper interests in South America via a joint venture with Canada’s Lundin Mining which in turn would offer $3. 25bn to acquire Filo Corp.
Standard Chartered unveils $1.5bn share buyback as profits beat estimates
Asia-focused bank Standard Chartered on Tuesday unveiled its biggest-ever share buyback and lifted guidance as interim earnings beat estimates.